153 related articles for article (PubMed ID: 15995618)
21. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
22. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
Sanz-Viedma S; Torigian DA; Parsons M; Basu S; Alavi A
Rev Esp Med Nucl; 2009; 28(3):159-66. PubMed ID: 19558958
[No Abstract] [Full Text] [Related]
23. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
Mirpour S; Meteesatien P; Khandani AH
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):71-7. PubMed ID: 22088805
[TBL] [Abstract][Full Text] [Related]
24. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K
Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302
[TBL] [Abstract][Full Text] [Related]
25. Two decades at the cross-roads of biology, physics and epidemiology: lessons learned in [18F-]FDG positron emission tomography in oncology.
Rizvi SN; Comans EF; Boellaard R; van Tinteren H; Hoekstra OS
Eur J Cancer; 2010 Aug; 46(12):2150-8. PubMed ID: 20561780
[TBL] [Abstract][Full Text] [Related]
26. Oncologic
Montilla-Soler JL; Makanji RJ; Barron BJ
Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
[TBL] [Abstract][Full Text] [Related]
27. Clinically unrecognized pulmonary aspiration during gastrointestinal endoscopy with sedation: a potential pitfall interfering the performance of 18F-FDG PET for cancer screening.
Hsieh TC; Wu YC; Ding HJ; Wang CH; Yen KY; Sun SS; Yeh JJ; Kao CH
Eur J Radiol; 2011 Dec; 80(3):e510-5. PubMed ID: 21439750
[TBL] [Abstract][Full Text] [Related]
28. Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Iagaru A; Mittra E; Mosci C; Dick DW; Sathekge M; Prakash V; Iyer V; Lapa P; Isidoro J; de Lima JM; Gambhir SS
J Nucl Med; 2013 Feb; 54(2):176-83. PubMed ID: 23243299
[TBL] [Abstract][Full Text] [Related]
29. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology.
Ziai P; Hayeri MR; Salei A; Salavati A; Houshmand S; Alavi A; Teytelboym OM
Radiographics; 2016; 36(2):481-96. PubMed ID: 26963458
[TBL] [Abstract][Full Text] [Related]
30. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic role of (18)F fluorodeoxyglucose positron emission tomography in patients with fever of unknown origin.
Sioka C; Assimakopoulos A; Fotopoulos A
Eur J Clin Invest; 2015 Jun; 45(6):601-8. PubMed ID: 25823953
[TBL] [Abstract][Full Text] [Related]
32. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers 18F-Alfatide and 18F-FDG: A Comparative Analysis.
Wei YC; Hu X; Gao Y; Fu Z; Zhao W; Yu Q; Wang S; Zhu S; Li J; Yu J; Yuan S
PLoS One; 2015; 10(9):e0136195. PubMed ID: 26352404
[TBL] [Abstract][Full Text] [Related]
34. 18F FDG-PET imaging in musculoskeletal infection.
Stumpe KD; Strobel K
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):131-42. PubMed ID: 16770303
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination].
Minamimoto R; Senda M; Jinnouchi S; Yoshida T; Nakashima R; Nishizawa S; Terauchi T; Kawamoto M; Inoue T
Kaku Igaku; 2009 Jun; 46(2):73-93. PubMed ID: 19637819
[TBL] [Abstract][Full Text] [Related]
36. Utility of 18F-FDG PET in evaluating cancers of lung.
Acker MR; Burrell SC
J Nucl Med Technol; 2005 Jun; 33(2):69-74; quiz 75-7. PubMed ID: 15930019
[TBL] [Abstract][Full Text] [Related]
37. 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis.
Hungenbach S; Delank KS; Dietlein M; Eysel P; Drzezga A; Schmidt MC
Nucl Med Commun; 2013 Nov; 34(11):1068-74. PubMed ID: 24025917
[TBL] [Abstract][Full Text] [Related]
38. Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study.
Kojima S; Zhou B; Teramukai S; Hara A; Kosaka N; Matsuo Y; Suzuki H; Torigoe S; Suzuki T; Uno K; Fukushima M
Eur J Cancer; 2007 Aug; 43(12):1842-8. PubMed ID: 17614273
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG imaging: pitfalls and artifacts.
Abouzied MM; Crawford ES; Nabi HA
J Nucl Med Technol; 2005 Sep; 33(3):145-55; quiz 162-3. PubMed ID: 16145222
[TBL] [Abstract][Full Text] [Related]
40. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]